Literature DB >> 19346692

Therapeutic efficacy of mammary irrigation regimen in dairy cattle diagnosed with acute coliform mastitis.

Yasunori Shinozuka1, Harumi Hirata, Ichiro Ishibashi, Yuzo Okawa, Asako Kasuga, Mitsuhiro Takagi, Yasuho Taura.   

Abstract

The objective of this field study was to determine the therapeutic efficacy of mammary irrigation for the treatment of dairy cattle diagnosed with acute coliform mastitis caused by gram-negative bacteria. Additionally, the effects of different mammary irrigation regimen fluids such as ozone water and normal saline were compared. Dairy cattle clinically diagnosed with acute coliform mastitis (n = 57) were enrolled in the study, randomly assigned to 1 of 3 groups, and received the following treatments: systemic antibiotic administration (SAA group; n = 40), mammary irrigation regimen (MIR group; n = 10), and both treatments (MIX group; n=7). Significant antipyretic effects, as assessed by rectal temperature measurement, were observed in the MIX and MIR groups. Although 2 irrigating fluids were used, namely, ozone water and normal saline, no significant difference was observed between the 2 groups. Fourteen days after the onset of the treatments, the milk yield recovery rate in MIR group tended to be higher (p = 0.06) than that in the SAA group. Additionally, after 30 days of treatment, the MIR group cows demonstrated significantly higher successful recovery rates (p<0.05) than the SAA group cows. These results indicate that mammary irrigation with normal saline is an effective treatment for acute coliform mastitis in dairy cattle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346692     DOI: 10.1292/jvms.71.269

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  1 in total

1.  Alterations in coagulation parameters in dairy cows affected with acute mastitis caused by E. coli and S. aureus pathogens.

Authors:  Zuhair A Bani Ismail; Charles Dickinson
Journal:  Vet Res Commun       Date:  2010-07-06       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.